REOLYSIN
Navigation Links
REOLYSIN in Medical News
Cedars-Sinai Medical Center opens patient trial of virus that attacks brain cancer cells
...id neurosurgeon John S. Yu, M.D., director of Surgical Neuro-oncology at Cedars-Sinais Department of Neurosurgery. Yu is principal investigator of the reolysin clinical trial at Cedars-Sinai. According to the protocol of this open-label Phase I and II trial, patients will receive a single treatment of REO...Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
...terim results from a U.K. Phase Ia/Ib combination reolysin and radiation clinical trial for patients with adv...the trial received two intratumoural treatments of reolysin at dosages of 1x108, 1x109, or 1x1010 TCID50 with ...ved either two, four or six intratumoural doses of reolysin at 1x1010 TCID50 with a constant localized radiati...Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs
... investigators examining various co-therapies with reolysin is providing Oncolytics with the rationale for its...fficer at Oncolytics. "This research suggests that reolysin can be combined with many existing therapies that ...he treatment of cancer patients." Currently, reolysin is being used in Phase I and Phase I/II human clin...REOLYSIN in Medical Technology
Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S. Phase I REOLYSIN Trial
CALGARY, June 05, 2007 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") announced today positive results from its U.S. Phase I clinical trial examining the systemic administration of REOLYSIN(R) in patients with advanced cancers. The results indicate that REOLYSIN(R) can be delivere......ating delivery of REOLYSIN, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown risks and uncertainties,... and resources to pursue research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studie...
REOLYSIN in Biological News
Oncolytics Biotech, Inc. announces publication of research
...appears online in the January 1, 2008 issue of Clinical Cancer Research. This exciting Mayo Clinic work supported the initiation of our combination reolysin and cyclophosphamide clinical trial, recently approved by the U.K. health authorities, said Dr. Matt Coffey, Chief Scientific Officer of Oncolytics. ...Dealing deadly cancers a knockout punch
...melanomas. Recent studies also indicate that reolysin works synergistically with standard anti-cancer dr...ther studies completed in the past year have shown reolysin has the ability to prime patients' immune systems ...ond "inflammatory" mechanism that researchers hope reolysin will bring about long-term remissions of once-untr...REOLYSIN in Biological Technology
Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results
...ed by our investigators, reinforce our belief that reolysin has the potential to significantly improve treatme...ASCO demonstrating that the combination of reolysin and gemcitabine in a U.K. Phase I trial was well t... - Presented a poster at ASCO that indicated reolysin was well tolerated and demonstrated anti-t...Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)
...y completed an initial 100-litre production run of reolysin under cGMP conditions. This run is anticipated to ...s, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown...research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely comp...Oncolytics Biotech(R) Inc. Completes Lyophilization Process for REOLYSIN(R)
...the lyophilization process, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown risks and uncertainties,... and resources to pursue research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studie......ating delivery of REOLYSIN, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown risks and uncertainties,... and resources to pursue research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studie...
...e Phase II component of a Phase I/II U.K. trial of reolysin combined with paclitaxel/carboplatin for patients ... Phase III pivotal program now being developed for reolysin in combination with carboplatin/paclitaxel for hea...atory Phase II trial using the same combination of reolysin and carboplatin/paclitaxel for patients with head ...
...ntation, entitled "A Phase II Study of Intravenous reolysin (Wild-type Reovirus) in the Treatment of Patients ...es in whom the IDD group are investigating various reolysin regimens," said Dr. Frank Giles, Director, IDD, an... Deputy Director, CTRC at UTHSCSA. Additional reolysin results presented Two additional poster prese...
...d today that data from three clinical trials using reolysin are scheduled to be presented at the 2009 American...he ASCO website today at www.asco.org . reolysin poster presentations - Dr. Monica Mita and ... I Study of the Combination of Intravenous reolysin (REO) and Gemcitabine (GEM) in Patients (pts) ...
Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study
... antitumour activity of intravenous, multiple dose reolysin in patients with bone and soft tissue sarcomas metastatic to the lung. reolysin is delivered intravenously to patients at a dose o...al and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown...Oncolytics Biotech(R) Inc. Announces 2009 First Quarter Results
...l benefit in the majority of patients treated with reolysin in combination with chemotherapy or radiation, pav... results from a U.K. Phase I/II combination reolysin and paclitaxel/carboplatin trial for patients with...Announced positive results from a U.K. combination reolysin and docetaxel trial for patients with a var...Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting
... results, performance or expectations implied by these forward-looking statements. Such risks and uncertainties include, among others, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studies and trials, uncertainties related to the research and development of phar...Other TagsfacedontoontoontoOther Contentsbreedbreedbreedbreedbranchbranchbranchbranchbranchbranchbranchbronchibronchibronchiolesborderborderborderborderbrushbrushbrushbrushbrushbuddingbuddingbuddingbuddingbudding
(Date:12/1/2009)...velopment of simple screening test, expert says ,... a finding that could lead to a simple blood test ...dentified immune system markers that indicate earl...g cancer. , The researchers examined gene expre...ith non-small cell lung cancer and a control group...
(Date:12/1/2009)...would benefit from liver surgery after chemo, stud... News) -- A CT scan of liver tumors caused by the ...ll survival after chemotherapy, researchers report...hemotherapy has been shown to improve survival in ...produce better results in patients having surgery ...
(Date:12/1/2009)...n because pandemic,s course remains unpredictable ...A U.S. health official said Tuesday that H1N1 swin...ly, but many experts agreed the virus could return...idespread in 32 states -- down from 43 states the ...e U.S. Centers for Disease Control and Prevention ...
(Date:12/1/2009)..., 2009)The Clinical Research Building (CRB), at th...as been honored for its sustainability components....tablished by the U.S. Green Building Council and v...ute (GBCI). LEED is the nation,s preeminent progra...een buildings., "Having a LEED certified building...
(Date:12/1/2009)... Ever thought you could quit smoking while you,re ...roundbreaking new system for quitting is easy, pai...enty eight days your cravings and desire to smoke ... (PRWEB) December 1, 2009 -- Izabella had tried...iction to nicotine, smoking at least a pack a day....
Breaking Medicine News(10 mins):Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:UM Clinical Research Building awarded prestigious LEED Building Certification 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3(Date:12/1/2009)... December 1, 2009: OptiNose is pleased to announce...ical study investigating the efficacy and tolerabi...for the topical treatment of chronic rhinosinusiti...ournal of the International and European Rhinologi...l polyps is a chronic disease that can significant...
(Date:12/1/2009)... This release is available in German . , Bro.... It contains loads of mitochondria, miniature po...at. In doing this, they normally generate a voltag...s energy for cellular processes. However, the mito...They go full steam ahead all the time. The energy ...
(Date:12/1/2009)... Yehezkel Ben-Ari, winner of the 2009 Inserm Grand...ed its commitment to paying tribute to outstanding...ts. By honouring talents, Inserm intends to,demon...lved in today,s biological, medical and,health re...and women who carry out and,drive this research e...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Brown fat cells make 'spare tires' shrink 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Wound Management Technologies Acquires Resorbable Orthopedics 5146 1Wound Management Technologies Acquires Resorbable Orthopedics 5146 2Wound Management Technologies Acquires Resorbable Orthopedics 5146 3Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 1Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 2Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 3Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 1Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 2Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 3Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |